Key Takeaways
- • Welltower is divesting a $6 billion medical office portfolio comprising 296 buildings across 34 states and 18 million square feet to Chicago-based Remedy Medical Properties, with the first $2 billion tranche closing in October 2025 and remaining assets expected to close by mid-2026.
- • The sale is part of "Welltower 3.0," a strategic reorientation toward senior housing; the company announced $14 billion in senior housing acquisitions across more than 700 communities in the U.S., U.K., and Canada, including a $6.9 billion acquisition of 111 U.K. communities from Barchester Healthcare.
- • Welltower reported third-quarter funds from operations of $1.34 per share, a 21 percent year-over-year increase, with $1.8 billion in acquisitions during the quarter alone, demonstrating strong operational momentum tied to the strategic pivot.
- • The divestiture will leave Welltower's medical office portfolio focused on long-term, triple-net leased assets while eliminating operationally intensive properties; 170 Welltower employees will transition to Remedy as part of the transaction.
- • Welltower's stock has surged approximately 40 percent year-to-date, with the company's market capitalization exceeding $120 billion, reflecting investor confidence in the senior housing repositioning strategy.
Summary
Welltower, the Toledo-based healthcare-focused real estate investment trust, is executing a major portfolio reorientation by offloading $6 billion in medical office assets while aggressively expanding its senior housing footprint. The company announced the sale of 18 million square feet of outpatient medical office space spanning 296 buildings across 34 states to Chicago-based Remedy Medical Properties, with backing from Kayne Anderson Real Estate. Remedy paid $2 billion for the initial tranche in October 2025, with the remaining properties expected to close by mid-2026. The portfolio carries a 94 percent occupancy rate and will expand Remedy's medical office footprint by approximately 60 percent upon completion.
The strategic repositioning, branded as "Welltower 3.0," represents a decisive shift away from operationally complex medical office properties toward the higher-margin senior housing sector. In its third-quarter earnings announcement, Welltower detailed $14 billion in senior housing acquisitions spanning more than 700 communities across the U.S., U.K., and Canada. The flagship transaction is a $6.9 billion acquisition of 111 U.K. senior communities from operator Barchester Healthcare, with occupancy rates near 80 percent. Domestically, Welltower has closed or signed contracts for $4 billion in East Coast senior housing assets covering 150 communities. The company plans to redeploy sale proceeds from the medical office divestiture, combined with credit paydowns and existing cash reserves, to fund these acquisitions.
The financial impact has been immediate and substantial. Welltower reported third-quarter funds from operations of $1.34 per share, representing a 21 percent year-over-year increase, with $1.8 billion in acquisitions completed during the single quarter. The market has responded positively to the strategic realignment, with Welltower's stock appreciating approximately 40 percent year-to-date as of October 2025. With a market capitalization exceeding $120 billion, the company has positioned itself to capitalize on secular tailwinds in senior housing driven by aging demographics. Upon completion of the medical office sale, Welltower's remaining medical office portfolio will consist primarily of long-term, triple-net leased assets, substantially reducing operational complexity. The transaction includes the transition of 170 Welltower employees to Remedy, reflecting the scale and operational nature of the divested properties.
The strategic repositioning, branded as "Welltower 3.0," represents a decisive shift away from operationally complex medical office properties toward the higher-margin senior housing sector. In its third-quarter earnings announcement, Welltower detailed $14 billion in senior housing acquisitions spanning more than 700 communities across the U.S., U.K., and Canada. The flagship transaction is a $6.9 billion acquisition of 111 U.K. senior communities from operator Barchester Healthcare, with occupancy rates near 80 percent. Domestically, Welltower has closed or signed contracts for $4 billion in East Coast senior housing assets covering 150 communities. The company plans to redeploy sale proceeds from the medical office divestiture, combined with credit paydowns and existing cash reserves, to fund these acquisitions.
The financial impact has been immediate and substantial. Welltower reported third-quarter funds from operations of $1.34 per share, representing a 21 percent year-over-year increase, with $1.8 billion in acquisitions completed during the single quarter. The market has responded positively to the strategic realignment, with Welltower's stock appreciating approximately 40 percent year-to-date as of October 2025. With a market capitalization exceeding $120 billion, the company has positioned itself to capitalize on secular tailwinds in senior housing driven by aging demographics. Upon completion of the medical office sale, Welltower's remaining medical office portfolio will consist primarily of long-term, triple-net leased assets, substantially reducing operational complexity. The transaction includes the transition of 170 Welltower employees to Remedy, reflecting the scale and operational nature of the divested properties.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.